Chapter/Section Purchase

1 Introduction to Research & Analysis Reports
1.1 Nucleic Acid-Based Multiplex Assays Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Nucleic Acid-Based Multiplex Assays Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Nucleic Acid-Based Multiplex Assays Overall Market Size
2.1 Global Nucleic Acid-Based Multiplex Assays Market Size: 2022 VS 2029
2.2 Global Nucleic Acid-Based Multiplex Assays Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Nucleic Acid-Based Multiplex Assays Players in Global Market
3.2 Top Global Nucleic Acid-Based Multiplex Assays Companies Ranked by Revenue
3.3 Global Nucleic Acid-Based Multiplex Assays Revenue by Companies
3.4 Top 3 and Top 5 Nucleic Acid-Based Multiplex Assays Companies in Global Market, by Revenue in 2022
3.5 Global Companies Nucleic Acid-Based Multiplex Assays Product Type
3.6 Tier 1, Tier 2 and Tier 3 Nucleic Acid-Based Multiplex Assays Players in Global Market
3.6.1 List of Global Tier 1 Nucleic Acid-Based Multiplex Assays Companies
3.6.2 List of Global Tier 2 and Tier 3 Nucleic Acid-Based Multiplex Assays Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Nucleic Acid-Based Multiplex Assays Market Size Markets, 2022 & 2029
4.1.2 Reagents & Consumables
4.1.3 Instruments & Accessories
4.1.4 Software & Services
4.2 By Type - Global Nucleic Acid-Based Multiplex Assays Revenue & Forecasts
4.2.1 By Type - Global Nucleic Acid-Based Multiplex Assays Revenue, 2018-2023
4.2.2 By Type - Global Nucleic Acid-Based Multiplex Assays Revenue, 2024-2029
4.2.3 By Type - Global Nucleic Acid-Based Multiplex Assays Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Nucleic Acid-Based Multiplex Assays Market Size, 2022 & 2029
5.1.2 Companion Diagnostics
5.1.3 Research & Development
5.1.4 Clinical Diagnostics
5.2 By Application - Global Nucleic Acid-Based Multiplex Assays Revenue & Forecasts
5.2.1 By Application - Global Nucleic Acid-Based Multiplex Assays Revenue, 2018-2023
5.2.2 By Application - Global Nucleic Acid-Based Multiplex Assays Revenue, 2024-2029
5.2.3 By Application - Global Nucleic Acid-Based Multiplex Assays Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Nucleic Acid-Based Multiplex Assays Market Size, 2022 & 2029
6.2 By Region - Global Nucleic Acid-Based Multiplex Assays Revenue & Forecasts
6.2.1 By Region - Global Nucleic Acid-Based Multiplex Assays Revenue, 2018-2023
6.2.2 By Region - Global Nucleic Acid-Based Multiplex Assays Revenue, 2024-2029
6.2.3 By Region - Global Nucleic Acid-Based Multiplex Assays Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Nucleic Acid-Based Multiplex Assays Revenue, 2018-2029
6.3.2 US Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.3.3 Canada Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.3.4 Mexico Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Nucleic Acid-Based Multiplex Assays Revenue, 2018-2029
6.4.2 Germany Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.4.3 France Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.4.4 U.K. Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.4.5 Italy Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.4.6 Russia Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.4.7 Nordic Countries Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.4.8 Benelux Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Nucleic Acid-Based Multiplex Assays Revenue, 2018-2029
6.5.2 China Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.5.3 Japan Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.5.4 South Korea Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.5.5 Southeast Asia Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.5.6 India Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Nucleic Acid-Based Multiplex Assays Revenue, 2018-2029
6.6.2 Brazil Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.6.3 Argentina Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Nucleic Acid-Based Multiplex Assays Revenue, 2018-2029
6.7.2 Turkey Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.7.3 Israel Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.7.4 Saudi Arabia Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
6.7.5 UAE Nucleic Acid-Based Multiplex Assays Market Size, 2018-2029
7 Nucleic Acid-Based Multiplex Assays Companies Profiles
7.1 Luminex
7.1.1 Luminex Company Summary
7.1.2 Luminex Business Overview
7.1.3 Luminex Nucleic Acid-Based Multiplex Assays Major Product Offerings
7.1.4 Luminex Nucleic Acid-Based Multiplex Assays Revenue in Global Market (2018-2023)
7.1.5 Luminex Key News & Latest Developments
7.2 Thermo Fisher Scientific
7.2.1 Thermo Fisher Scientific Company Summary
7.2.2 Thermo Fisher Scientific Business Overview
7.2.3 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Major Product Offerings
7.2.4 Thermo Fisher Scientific Nucleic Acid-Based Multiplex Assays Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Scientific Key News & Latest Developments
7.3 Illumina
7.3.1 Illumina Company Summary
7.3.2 Illumina Business Overview
7.3.3 Illumina Nucleic Acid-Based Multiplex Assays Major Product Offerings
7.3.4 Illumina Nucleic Acid-Based Multiplex Assays Revenue in Global Market (2018-2023)
7.3.5 Illumina Key News & Latest Developments
7.4 Bio-Rad Lab
7.4.1 Bio-Rad Lab Company Summary
7.4.2 Bio-Rad Lab Business Overview
7.4.3 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Major Product Offerings
7.4.4 Bio-Rad Lab Nucleic Acid-Based Multiplex Assays Revenue in Global Market (2018-2023)
7.4.5 Bio-Rad Lab Key News & Latest Developments
7.5 QIAGEN
7.5.1 QIAGEN Company Summary
7.5.2 QIAGEN Business Overview
7.5.3 QIAGEN Nucleic Acid-Based Multiplex Assays Major Product Offerings
7.5.4 QIAGEN Nucleic Acid-Based Multiplex Assays Revenue in Global Market (2018-2023)
7.5.5 QIAGEN Key News & Latest Developments
7.6 BD
7.6.1 BD Company Summary
7.6.2 BD Business Overview
7.6.3 BD Nucleic Acid-Based Multiplex Assays Major Product Offerings
7.6.4 BD Nucleic Acid-Based Multiplex Assays Revenue in Global Market (2018-2023)
7.6.5 BD Key News & Latest Developments
7.7 Abcam
7.7.1 Abcam Company Summary
7.7.2 Abcam Business Overview
7.7.3 Abcam Nucleic Acid-Based Multiplex Assays Major Product Offerings
7.7.4 Abcam Nucleic Acid-Based Multiplex Assays Revenue in Global Market (2018-2023)
7.7.5 Abcam Key News & Latest Developments
7.8 Seegene
7.8.1 Seegene Company Summary
7.8.2 Seegene Business Overview
7.8.3 Seegene Nucleic Acid-Based Multiplex Assays Major Product Offerings
7.8.4 Seegene Nucleic Acid-Based Multiplex Assays Revenue in Global Market (2018-2023)
7.8.5 Seegene Key News & Latest Developments
7.9 Meso Scale Diagnostics
7.9.1 Meso Scale Diagnostics Company Summary
7.9.2 Meso Scale Diagnostics Business Overview
7.9.3 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Major Product Offerings
7.9.4 Meso Scale Diagnostics Nucleic Acid-Based Multiplex Assays Revenue in Global Market (2018-2023)
7.9.5 Meso Scale Diagnostics Key News & Latest Developments
7.10 Randox Laboratories
7.10.1 Randox Laboratories Company Summary
7.10.2 Randox Laboratories Business Overview
7.10.3 Randox Laboratories Nucleic Acid-Based Multiplex Assays Major Product Offerings
7.10.4 Randox Laboratories Nucleic Acid-Based Multiplex Assays Revenue in Global Market (2018-2023)
7.10.5 Randox Laboratories Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer